Attn: Perchlorate_Comments_for OIG@epa
نویسندگان
چکیده
Objective: A significant negative association between serum thyroxine and urine perchlorate levels had been reported from NHANES 2001-2002 by Blount et al. (2006) for women age 12-85 with low iodine nutrition expressed as urine iodine (UI) less than 100 ug/l. We have reanalyzed the data using creatinine-adjusted urine iodine (UICr) as the measure of iodine nutrition and focused on women of childbearing age (age 15-44). UICr (creatinine-adjusted urine iodine) may better reflect 24-hour urine iodine excretion than does the UI (Manz, 2000; Thomson, 2001). Additionally, we have included urinary measures of the other two major iodine uptake inhibitors, nitrate and thiocyanate. Design: Of 2091 women of child-bearing age [WCBA], 625 had serum measurements for thyroxine and urinary measurements for iodine, creatinine, and the three iodineuptake inhibitors. Additional exclusions were made for thyroid history and extreme values. Multiple regression analyses on the thyroxine level were performed for each tercile of the UI distribution and of the UICr distribution, both with and without population-weighting, and including the three iodine-uptake inhibitors. Main Outcome: With iodine nutrition expressed as creatinine-adjusted urinary iodine, a significant negative association with serum thyroxine was found at high iodine levels rather than at low iodine levels for both urine perchlorate and urine thiocyanate levels.. Additionally, urinary thiocyanate levels were consistently found to have a significant negative association with serum thyroxine level at high iodine level, whether creatinineadjusted or not, whether population-adjusted or not. Conclusion: A variety of analytic methods, including Sudaan-weighting, consistently revealed that the negative association of serum thyroxine and urine perchlorate found for WCBA with low iodine defined by UI was not found for those with low iodine defined by UICr (creatinine-adjusted). March 10, 2009 CEOH Page 1 of 11 Perchlorate and Thyroxine: Creatinine and Population Adjustment
منابع مشابه
Implementation of the Commercial Advertisement Loudness Mitigation (calm) Act
• Mail: U.S. Environmental Protection Agency, Region III, Attn: Darius Ostrauskas (3HS23), 1650 Arch Street, Philadelphia, PA 19103–2029. • Hand Delivery: U.S. Environmental Protection Agency, Region III, Attn: Darius Ostrauskas (3HS23), 1650 Arch Street, Philadelphia, PA 19103–2029, Phone: 215–814–3360, Business Hours: Mon. thru Fri.—9 a.m. to 4 p.m. Such deliveries are only accepted during th...
متن کاملNeuroprotective Effects of α-Tocotrienol on Kainic Acid-Induced Neurotoxicity in Organotypic Hippocampal Slice Cultures
Vitamin E, such as alpha-tocopherol (ATPH) and alpha-tocotrienol (ATTN), is a chain-breaking antioxidant that prevents the chain propagation step during lipid peroxidation. In the present study, we investigated the effects of ATTN on KA-induced neuronal death using organotypic hippocampal slice culture (OHSC) and compared the neuroprotective effects of ATTN and ATPH. After 15 h KA (5 µM) treatm...
متن کاملInside IAQ, Fall/Winter 1998
Inside IAQ is distributed twice a year and highlights indoor air quality (IAQ) research conducted by EPA’s National Risk Management Research Laboratory’s (NRMRL’s) Indoor Environment Management Branch (IEMB) and other parts of EPA’s Office of Research and Development. If you would like to be added to or removed from the mailing list, please mail, fax, or e-mail your name and address to; Inside ...
متن کاملTop Management Challenges FY 2009
The Top Management Challenges identified by the Office of the Inspector General (OIG) for the Department of Labor (DOL) are discussed below. The Department’s responses and presentation of its progress on the Top Management Challenges are shown following the OIG report. 2009 Top Management Challenges Facing the Department of Labor For 2009, the OIG considers the following as the most serious m...
متن کاملPublication of the OIG compliance program guidance for hospitals--OIG. Notice.
This Federal Register notice sets forth the recently issued compliance program guidance for hospitals developed by the Office of Inspector General (OIG) in cooperation with, and with input from, several provider groups and industry representatives. Many providers and provider organizations have expressed an interest in better protecting their operations from fraud and abuse through the adoption...
متن کامل